Medical News Podcast
The Medical News Podcast by PeerDirect delivers news and interviews with clinical thought leaders and researchers to keep you informed of the latest breakthroughs, guidelines, and insights in your specialty. Designed for clinicians with stories selected by the PeerDirect editorial board. Visit us at peerdirect.com to sign-up for our newsletter.
- Update frequency
- every 2 days
- Average duration
- 9 minutes
- Episodes
- 288
- Years Active
- 2023 - 2025
Emerging Therapies in SLE: Recent Studies and Potential Game-Changing Treatments
Drs. Fava and Petri discuss emerging therapies in systemic lupus erythematosus, including treatments for lupus nephritis and cutaneous disease.
00:08:55 |
Fri 05 Sep 2025
Non-Invasive Biomarkers in SLE: A Promise of Better Diagnosis, Management, and Personalized Treatment?
Drs. Petri and Fava review non-invasive biomarkers in systemic lupus erythematosus, including urine proteomics.
00:12:42 |
Thu 04 Sep 2025
New Guidelines for the Screening, Treatment, and Management of Lupus Nephritis
Drs. Petri and Fava discuss updated guidelines for the screening, treatment, and management of lupus nephritis.
00:13:28 |
Wed 03 Sep 2025
What does FDA’s approval of generic liraglutide mean for obesity care?
The FDA has approved a generic version of liraglutide injection, expanding access to obesity treatment by lowering costs and broadening eligibility across adults and adolescents, though safety monito…
00:05:06 |
Tue 02 Sep 2025
How will the first approval for MASH with fibrosis alter treatment pathways?
The FDA has granted accelerated approval to semaglutide (Wegovy) as the first drug for metabolic dysfunction–associated steatohepatitis (MASH), showing significant improvements in liver health and we…
00:04:57 |
Wed 27 Aug 2025
How are telehealth abortion prescriptions reaching ban states?
A new JAMA study found that 84% of abortion prescriptions from Aid Access went to patients in states with bans, enabled by “shield laws” protecting telehealth providers across state lines. Provision …
00:04:50 |
Wed 20 Aug 2025
Can a smartphone app reduce suicide attempts after psychiatric hospitalization?
A multi-site randomized trial found that the suicide-prevention app OTX202 reduced repeat suicide attempts by 58% and sustained lower suicidal ideation through 24 weeks, especially in high-risk patie…
00:04:59 |
Tue 12 Aug 2025
Can blood tests reliably guide Alzheimer’s diagnosis in patients with cognitive decline?
New guidelines from the 2025 Alzheimer’s Association International Conference support using high-performing blood tests to help diagnose Alzheimer’s in memory care patients, offering a less invasive …
00:05:19 |
Wed 06 Aug 2025
How do sulfonylureas compare to DPP-4 inhibitors for cardiovascular safety in T2D?
A large observational study found small but potentially meaningful differences in cardiovascular safety among sulfonylureas compared to DPP-4 inhibitors in type 2 diabetes, with glipizide showing a s…
00:05:40 |
Tue 05 Aug 2025
Could methotrexate replace prednisone as first-line therapy in lung sarcoidosis?
A new NEJM trial found methotrexate offers similar lung function improvements as prednisone in pulmonary sarcoidosis, but with fewer side effects—suggesting it could be a safer first-line option for …
00:04:12 |
Wed 30 Jul 2025
Geographic Atrophy: Where Do We Stand and Where are We Going?
Drs. Patel and Armstrong discuss how they are integrating FDA-approved therapies into geographic atrophy care. They share their perspectives on emerging treatments, including the potential for combin…
00:11:41 |
Tue 29 Jul 2025
Advances in Retinal Therapy: Emerging Strategies for DME and wAMD
Drs. Armstrong and Patel discuss current and emerging therapies for diabetes-related macular edema and wet age-related macular degeneration including anti-VEGF agents, the need for durability and red…
00:12:11 |
Mon 28 Jul 2025
Richard Ostfeld on Tick-Borne Threats in Changing Ecosystems
Dr. Richard S. Ostfeld discusses how human disruption of natural ecosystems, such as forest fragmentation and predator loss, has increased the risk of tick-borne diseases like Lyme and Powassan virus…
00:24:13 |
Fri 25 Jul 2025
AI and Telehealth in Diabetic Retinopathy: From Screening to Specialist Care
Drs. Patel and Armstrong discuss the implementation and evaluation of AI-powered diabetic retinopathy and diabetes-related macular edema screening and telemedicine, including ways to handle an influx…
00:09:03 |
Tue 22 Jul 2025
GLP-1s and the Retinal Patient: What Every Eye Care Professional Should Know
Drs. Modi and Dedania discuss GLP-1 receptor agonists and the retinal patient, including how GLP-1 receptor agonists work, benefits and risks in patients with retinal disease, and data from retrospec…
00:10:35 |
Mon 21 Jul 2025
Floaters: Imaging Tools, Decision-Making, Including Surgery and Patient Counseling
Drs. Dedania and Modi discuss vitreous opacities, or floaters, including imaging, evaluating, and when and whether to pursue surgery. They discuss conditional circumstances that may influence whether…
00:09:33 |
Fri 18 Jul 2025
Geographic Atrophy: Navigating the Latest Advances in Care
Drs. Modi and Dedania discuss imaging, biomarkers, and diagnosis in geographic atrophy, as well as current therapies and those in late stage clinical trials.
00:09:37 |
Thu 17 Jul 2025
“What does full FDA approval of Moderna’s COVID vaccine mean for high-risk kids under 12?”
This podcast highlights three updates: Moderna’s Spikevax COVID-19 vaccine is now fully FDA-approved for high-risk children 6 months to 11 years, though rare myocarditis remains a concern. A large st…
00:04:36 |
Wed 16 Jul 2025
Maintenance Therapy Strategies in Small Cell Lung Cancer
Drs. Sabari and Socinski discuss maintenance therapy strategies in small cell lung cancer, including immunotherapy, chemotherapy, targeted agents, and radiation.
00:13:23 |
Mon 14 Jul 2025
ASCO 2025: Emerging Therapies in Small Cell Lung Cancer
Drs. Socinski and Sabari discuss a couple of abstracts from ASCO 2025 about emerging therapeutics in small cell lung cancer.
00:09:23 |
Fri 11 Jul 2025
Disclaimer: The podcast and artwork embedded on this page are the property of PeerDirect, 1140 Avenue of the Americas, 14th Floor, New York, NY 10036. This content is not affiliated with or endorsed by eachpod.com.